Cargando…

A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection

A number of antiviral agents used against Human Immunodeficiency Virus (HIV) infection and hepatitis B virus (HBV) mono or co-infection have been associated with real nephrotoxicity (including tenofovir disoproxil fumarate (TDF), atazanavir, indinavir and lopinavir) or apparent changes in renal func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holt, Stephen G, Gracey, David M, Levy, Miriam T, Mudge, David W, Irish, Ashley B, Walker, Rowan G, Baer, Richard, Sevastos, Jacob, Abbas, Riaz, Boyd, Mark A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350301/ https://www.ncbi.nlm.nih.gov/pubmed/25745499 http://dx.doi.org/10.1186/1742-6405-11-35

Ejemplares similares

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
por: Pan, Calvin Q., et al.
Publicado: (2021)

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
por: Puri, Ashana, et al.
Publicado: (2019)

Exosomal lncRNA HOTTIP Mediates Antiviral Effect of Tenofovir Alafenamide (TAF) on HBV Infection
por: Liu, Qing-Min, et al.
Publicado: (2021)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Home blood pressure monitoring: Australian Expert Consensus Statement
por: Sharman, James E., et al.
Publicado: (2015)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy
por: Dunkley, Scott, et al.
Publicado: (2019)

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
por: Truong, Steven L., et al.
Publicado: (2021)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service
por: Turner, Dane, et al.
Publicado: (2019)

It is time for consensus on ‘consensus statements’
por: Blazey, Paul, et al.
Publicado: (2022)

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China
por: Hou, Jinlin, et al.
Publicado: (2021)

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
por: Zhou, Jing, et al.
Publicado: (2021)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
por: Yang, Young-Mo, et al.
Publicado: (2017)

Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019)

Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury: Consensus statement
por: Hutchinson, Peter J., et al.
Publicado: (2019)

Consensus Statements on the Assessment of Older Drivers
por: Hogan MD, David B., et al.
Publicado: (2014)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
por: Li, Pengpeng, et al.
Publicado: (2023)

Committee Reports & Consensus Statements
Publicado: (2009)

CONSENSUS STATEMENT ON THE MANAGEMENT OF URTICARIA
por: Godse, Kiran V, et al.
Publicado: (2011)

Consensus statement on diabetes in children
por: Prasanna Kumar, K. M., et al.
Publicado: (2014)

Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report
por: Heron, Jack E., et al.
Publicado: (2020)

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
por: Gantner, Pierre, et al.
Publicado: (2019)

Homocysteine and Dementia: An International Consensus Statement(1)
por: Smith, A. David, et al.
Publicado: (2018)

Consensus statement from the international consensus meeting on post-traumatic cranioplasty
por: Iaccarino, C., et al.
Publicado: (2020)

A Consensus Statement on acromegaly therapeutic outcomes
por: Melmed, Shlomo, et al.
Publicado: (2018)

1591 Hepatitis B outcome in coinfected HIV-HBV individuals in the tenofovir/emtricitabine era
por: Nguyen, Divien, et al.
Publicado: (2014)

ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs
por: Webster, Cynthia R. L., et al.
Publicado: (2019)

Parma consensus statement on metabolic disruptors
por: Heindel, Jerrold J., et al.
Publicado: (2015)

ACVIM consensus statement on pancreatitis in cats
por: Forman, Marnin A., et al.
Publicado: (2021)

The 2020 NBA Orthobiologics Consensus Statement
por: Cole, Brian J., et al.
Publicado: (2021)

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
por: Lovett, Grace C, et al.
Publicado: (2017)

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
por: Yang, Na, et al.
Publicado: (2021)

Joint UK societies’ 2019 consensus statement on renal denervation
por: Lobo, Melvin D, et al.
Publicado: (2019)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant
por: Ratziu, Vlad, et al.
Publicado: (2006)

Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads
por: Lin, Yayun, et al.
Publicado: (2018)

Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy
por: Lee, I-Cheng, et al.
Publicado: (2022)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
por: Lu, Haohao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k9a6a16d32r6inhj562vedbrit